An Open-label Single and Repeat Dose Study to Investigate the Pharmacokinetic Profiles of Tenofovir Disoproxil Fumarate 300 mg in Healthy Chinese Subjects.
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Viral infections
- Focus Pharmacokinetics
- Acronyms PK of TDF
- Sponsors GlaxoSmithKline
- 20 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2011 Actual initiation date (Dec 2011) added as reported by ClinicalTrials.gov.
- 21 Dec 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.